lysine has been researched along with Eye Cancer, Retinoblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, S; Guo, H; Huang, G; Jiang, A; Mao, L; Sang, Y; Sun, X; Tao, J; Wu, W; Xu, C | 1 |
| Chai, P; Fan, J; Fan, X; Ge, S; Jia, R; Ni, H; Wang, S; Wang, Y; Xing, Y; Yu, J | 1 |
| Bhanap, B; Niedzwiecki, A; Rath, M; Roomi, MW; Roomi, N | 1 |
3 other study(ies) available for lysine and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.
Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Histone Demethylases; Humans; Hydrazines; Lysine; Retinal Neoplasms; Retinoblastoma; Signal Transduction; Sulfonamides | 2022 |
LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter.
Topics: Carcinogenesis; Cell Line; Class Ib Phosphatidylinositol 3-Kinase; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-akt; Retinoblastoma; RNA, Long Noncoding; Signal Transduction; Transcription, Genetic | 2020 |
Antineoplastic activity of a nutrient mixture in Y-79 malignant retinoblastoma cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Ascorbic Acid; Cell Adhesion; Cell Movement; Cell Proliferation; Flow Cytometry; Humans; Lysine; Plant Extracts; Proline; Retinoblastoma; Tea; Tumor Cells, Cultured | 2013 |